CTX121 Trademark

Trademark Overview


On Thursday, June 16, 2022, a trademark application was filed for CTX121 with the United States Patent and Trademark Office. The USPTO has given the CTX121 trademark a serial number of 97461207. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, May 31, 2023. This trademark is owned by CRISPR Therapeutics AG. The CTX121 trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer

Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development
ctx121

General Information


Serial Number97461207
Word MarkCTX121
Filing DateThursday, June 16, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, May 31, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer
Pseudo MarkCTX ONE TWO ONE; CTX ONE HUNDRED TWENTY ONE
Goods and ServicesGene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 30, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 30, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCRISPR Therapeutics AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZUG V8 SWITZERLAND 6300
CH

Trademark Events


Event DateEvent Description
Wednesday, May 31, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, May 31, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, May 31, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, February 14, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 14, 2023NON-FINAL ACTION E-MAILED
Tuesday, February 14, 2023NON-FINAL ACTION WRITTEN
Tuesday, February 7, 2023ASSIGNED TO EXAMINER
Thursday, June 30, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 20, 2022NEW APPLICATION ENTERED